Authors: Fagot, JP Flahault, A Fodil, M Kanfer, A Alamowitch, S Haymann, JP Lecomte, I Liote, H Parrot, A Rossert, J Verdy, E Becker, A

Citation: Jp. Fagot et al., Impact of expert recommendations on LMWH venous thromboembolism prophylaxis for non-surgery patients on physician prescriptions, PRESSE MED, 30(5), 2001, pp. 203-208

Authors: Debrix, I Tilleul, P Milleron, B Grene, N Bouleuc, C Roux, D Liote, H Madelaine, I Bellanger, A Conort, O Fontan, JE Le Mercier, F Bardin, C Becker, A

Citation: I. Debrix et al., The relationship between introduction of American Society of Clinical Oncology guidelines and the use of colony-stimulating factors in clinical practice in a Paris university hospital, CLIN THER, 23(7), 2001, pp. 1116-1127

Authors: Fagot, JP Flahault, A Kanfer, A Benoit, G Bellanger, A Conort, O Durand-Zaleski, I Liote, H Mangin, L Oliary, J Verdy, E Becker, A

Citation: Jp. Fagot et al., Prevention of venous thromboembolism in patients hospitalized for more than 24 hours in a medical ward: proposed indications for low molecular weightheparins, PRESSE MED, 29(1), 2000, pp. 4-10

Authors: Wislez, M Sibony, M Naccache, JM Liote, H Carette, MF Oksenhendler, E Cadranel, J

Citation: M. Wislez et al., Organizing pneumonia related to common variable immunodeficiency, RESPIRATION, 67(4), 2000, pp. 467-470

Authors: Roche, N Liote, H Housset, B

Citation: N. Roche et al., Comments on the guidelines of the French Society of Pneumology for use of serum tumor markers in the management of primary lung cancer, REV MAL RES, 16(6), 1999, pp. 1165-1166

Authors: Debrix, I Bouleuc, C Liote, H Milleron, B Beker, A

Citation: I. Debrix et al., Impact of American Society of Clinical Oncology guidelines for clinical use of colony-stimulating factors, J CL ONCOL, 17(10), 1999, pp. 3360-3361